CF PharmTech

company

About

CF PharmTech is a specialty pharmaceutical company that develops and manufactures inhalation products.

  • 11 - 50

Details

Last Funding Type
Series F
Last Funding Money Raised
¥360M
Industries
Health Care,Manufacturing,Pharmaceutical
Founded date
Jan 1, 2007
Number Of Employee
11 - 50
Operating Status
Active

CF PharmTech was founded in 2007, it is a fully independent, dynamic, integrated, specialty pharmaceutical company focused on the development and manufacturing of products for the treatments of asthma, COPD and allergic rhinitis for the global market. Its mission is to develop high-quality and affordable medicine to help patients achieve effective management care for their respiratory diseases. The headquarters is located in the lakeside of the Caohu District of Suzhou, Jiangsu Province, with many very convenient transportation options available. It only takes thirty minutes by train to Shanghai and four hours by train to Beijing.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥0.99B
CF PharmTech has raised a total of ¥0.99B in funding over 2 rounds. Their latest funding was raised on Jul 1, 2020 from a Series F round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 1, 2020 Series F ¥360M 4 Detail
Jan 1, 2020 Series E ¥630M 1 Detail

Investors

Number of Lead Investors
Number of Investors
5
CF PharmTech is funded by 5 investors. GP M&A Fund and CICC Qichen are the most recent investors.
Investor Name Lead Investor Funding Round
GP M&A Fund Series F
CICC Qichen Series F
Passion Capital Series F
Watson Investment Series F
Finnova Capital Series E